SATURDAY, DECEMBER 16, 2017

China reports two more cases of avian influenza

Hong Kong's Centre for Health Protection at the Department of Health received notification on Saturday of two more cases of avian influenza A(H7N9) in mainland China, bringing the confirmed number of cases on the mainland up to 440. Read More »

Mucosis to present needle-free vaccine to battle RSV infections

At a vaccine conference this week, biotechnology company Mucosis B.V. will present SynGEM, a needle-free vaccine that prevents respiratory syncytial virus (RSV) infections. Read More »

Louisiana reports two more West Nile cases

Despite the Ebola virus dominating national headlines recently, the Louisiana Department of Health & Hospitals says residents should be more worried about West Nile virus after two new patients were diagnosed last week. Read More »

Mississippi reports first case of the flu for the season

A Marshall County teenager become Mississippi's first confirmed influenza case of the 2014-2015 season last week, prompting state health officials to remind residents to get their flu shots. Read More »

CDC confirms 126 new cases of enterovirus in the U.S.

The United States has 126 new enterovirus D68 (EV-D68) cases, bringing the total number of cases in the nation to 922, the Centers for Disease Control and Prevention (CDC) confirmed today. Read More »

Rotary donates $44.7 million toward global effort to end polio

Rotary has donated $44.7 million to the Global Polio Eradication Initiative, which aims to wipe polio off the map by 2018. Read More »

FDA to review application for investigational pediatric hexavalent vaccine

The U.S. Read More »

U.N. officials gather in Cuba to discuss ways to prevent spread of Ebola

Health officials from the United Nations encouraged countries around the world on Monday to replicate the efforts of Cuba and Venezuela in stopping the spread of Ebola as the virus has evolved from being just a localized health issue. Read More »

Griffith University contributes to hPIV treatment research

New research from Griffith University's Institute for Glycomics may soon lead to the development of a treatment for Human parainfluenza virus (hPIV), an illness that results in countless hospitalizations and deaths every year. Read More »

H1N1 mutation muddles immune responses in adults

Scientists investigating why an unusually high number of middle-aged individuals contracted H1N1 influenza last year are blaming the increase on a newly discovered mutation in the virus. Read More »

Flu vaccine discovery could lead to heart disease vaccine

Heart disease is the most common cause of deaths worldwide, but researchers recently identified a molecular mechanism in the flu vaccine that could help create a heart disease vaccine. Read More »

Antigen Discovery receives NIH grant

California-based Antigen Discovery Inc. (ADi) has been awarded a National Institutes of Health (NIH) Phase I Small Business Innovation Research award (SBIR) from the National Institute of Dental and Craniofacial Research (NIDCR). Read More »

Sanofir Pasteur, Immune Design team up on herpes vaccine

The Center for the Biology of Chronic Disease (CBCD), a nonprofit organization, recently praised Sanofi Pasteur and Immune Design for collaborating on a new vaccine for HSV-2, a form of genital herpes. Read More »

Profectus Biosciences receives HHS funding to accelerate tests on Ebola vaccine

The U.S. Read More »

Monkeybar project uses drones to track malaria in Asia

The London School of Hygiene & Tropical Medicine believes drones can help with cutting costs when it comes to ecological research. Read More »

Studies show more TB cases worldwide than earlier estimates

New studies show that there are nearly 500,000 more cases of tuberculosis than was previously estimated. Read More »

DARPA provides $12.2 million to fund research on DNA-based mAbs treatments

The Defense Advanced Research Projects Agency (DARPA) funded $12.2 million for new treatments made possible through DNA-based monoclonal antibodies research. Read More »

Johnson & Johnson on fast track to develop new Ebola vaccine

Johnson & Johnson has made a commitment of up to $200 million to fast-track an Ebola vaccine currently in development at its Janssen Pharmaceutical Companies. Read More »

Profectus and GNL receive $8.5 million Army grant for vaccine development

Profectus BioSciences, Inc. and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston (UTMB) have received a three-year, $8.5 million grant from the Department of the Army, U.S. Read More »

Entervirus D68 expected to fade with colder temperatures

Experts have reassured the public that the number of particularly severe Enterovirus D68 (EV-D68) cases will decrease with coming winter temperatures. Read More »